EHHADH and hepatocellular carcinoma: The area under the curve (AUC) for EHHADH was determined to be 0.776 (95% confidence interval [CI]: 0.730–0.822; Figure 1j), indicating that EHHADH holds promise as a prognostic biomarker for HCC.